Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase 4 1

Status

Completed 234Unknown 77Recruiting 51Active not recruiting 33Terminated 27Not yet recruiting 20Withdrawn 9Suspended 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Paclitaxel 3Surgical Procedures, Operative 2Radiotherapy 2Oxaliplatin 2Magnetic Resonance Spectroscopy 2Fluorouracil 2Doxorubicin 2Cyclophosphamide 2titanium silicide 1sargramostim 1exemestane 1eribulin 1cemiplimab 1Vincristine 1Taxes 1Tamoxifen 1Surveys and Questionnaires 1Specimen Handling 1S 1 (combination) 1Rituximab 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Prednisone 1Prednisolone 1Passive Cutaneous Anaphylaxis 1Neoadjuvant Therapy 1Morphine 1Methylprednisolone 1Methotrexate 1Methods 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Suspended × Fluorouracil × Clear all
NCT00002696 2013-08-02

Combination Chemotherapy in Treating Women With Stage III Breast Cancer

National Cancer Institute (NCI)

Phase 3 Suspended
Breast

Breast Neoplasms

NCT00316745 2007-11-01

IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer

Hokkaido Gastrointestinal Cancer Study Group

Phase 3 Suspended
200 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡